How Epigenetic Blood Markers Help Understand Dementia Risk
New research highlights the use of epigenetic markers to better understand and predict dementia risk, including Alzheimer’s disease.
Read MorePosted by Andy Lundin | Aug 28, 2024 | Dementias & Alzheimer’s |
New research highlights the use of epigenetic markers to better understand and predict dementia risk, including Alzheimer’s disease.
Read MorePosted by Andy Lundin | Aug 2, 2024 | Dementias & Alzheimer’s |
Proteins associated with comorbid Alzheimer’s pathology in Parkinson’s dementia and dementia with Lewy bodies develop after the onset of the disease.
Read MorePosted by Andy Lundin | Jul 22, 2024 | Disease States |
A blood test detecting alpha-synuclein protein is a promising method for diagnosing Parkinson’s, potentially improving early detection.
Read MorePosted by Andy Lundin | Jul 8, 2024 | Dementias & Alzheimer’s |
Researchers discovered a pattern in the spinal fluid of patients with progressive supranuclear palsy using high-throughput technology.
Read MorePosted by Andy Lundin | Jun 18, 2024 | Disease States |
Researchers have developed a blood test using AI to predict Parkinson’s disease up to seven years before symptoms appear.
Read More